Jörg Hülsken
Max Delbrück Center for Molecular Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jörg Hülsken.
Developmental Biology | 2003
Dietmar Zechner; Yasuyuki Fujita; Jörg Hülsken; Thomas Müller; Ingrid Walther; Makoto M. Taketo; E. Bryan Crenshaw; Walter Birchmeier; Carmen Birchmeier
beta-Catenin is an essential component of the canonical Wnt signaling system that controls decisive steps in development. We employed here two conditional beta-catenin mutant alleles to alter beta-catenin signaling in the central nervous system of mice: one allele to ablate beta-catenin and the second allele to express a constitutively active beta-catenin. The tissue mass of the spinal cord and brain is reduced after ablation of beta-catenin, and the neuronal precursor population is not maintained. In contrast, the spinal cord and brain of mice that express activated beta-catenin is much enlarged in mass, and the neuronal precursor population is increased in size. beta-Catenin signals are thus essential for the maintenance of proliferation of neuronal progenitors, controlling the size of the progenitor pool, and impinging on the decision of neuronal progenitors to proliferate or to differentiate.
Current Opinion in Cell Biology | 1994
Jörg Hülsken; Jürgen Behrens; Walter Birchmeier
Various structural components of intercellular junctions have recently been found to represent (or be related to) products of tumor-suppressor genes. The tumor-suppressor gene product adenomatous polyposis coli (APC) binds to beta 2-catenin (homologous to the product of Drosophila armadillo), which is cytoplasmically associated with the cell adhesion molecule E-cadherin.
Current Topics in Microbiology and Immunology | 1996
Walter Birchmeier; Jürgen Behrens; K M Weidner; Jörg Hülsken; Carmen Birchmeier
Tumors of epithelial origin (carcinomas) are of major medical importance (DeVita et al. 1993). Multiple genetic changes in dominant and recessive oncogenes that contribute to carcinoma formation and progression have been identified. The most frequent mutations found in carcinomas include activating mutations in the ras family of genes, mutations that interfere with the function of p53, and amplification or overexpression of genes encoding tyrosine kinase receptors (Barbacid 1987; Aronson 1991; Hollstein et al. 1991; Vogelstein and Kinzler 1993; Hinds and Weinberg 1994). These mutations affect both the growth and the genetic stability of affected cells. A further critical step in the development of malignant carcinomas is their ability to invade the underlying tissue and to metastasize to distant sites. Early genetic approaches for the analysis of oncogenes have focused mainly on the induction of transformation, i.e., unregulated growth in fibroblasts, which has led in the past decade to a wealth of data on the pathways controlling normal and aberrant growth. In comparison, there has been a lag in understanding the molecular causes leading to the acquisition of the metastatic potential of carcinoma cells.
Cancer Letters | 1997
Claudia Denk; Jörg Hülsken; Elisabeth Schwarz
Cell-cell adhesion mediated by E-cadherin is often lost or disturbed in human carcinomas. For regular adhesive function, E-cadherin has to form complexes with peripheral cytoplasmic catenins which are multifunctional proteins that are also involved in signal transduction and growth regulation. We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas. Reduced mRNA and protein levels were detected for plakoglobin, whereas alpha- and beta-catenin showed only reduced protein (but not mRNA) levels. The alterations in catenin gene expression were often associated with absent or reduced E-cadherin. The findings indicate that a reduction of catenin gene expression may contribute to the development of cervical carcinomas.
Journal of Cell Biology | 1994
Jörg Hülsken; Walter Birchmeier; Jürgen Behrens
Development | 2002
Catherin Niemann; David M. Owens; Jörg Hülsken; Walter Birchmeier; Fiona M. Watt
Journal of Cell Biology | 2000
Martin M. Sachs; Henning Brohmann; Dietmar Zechner; Thomas Müller; Jörg Hülsken; Ingrid Walther; Ute Schaeper; Carmen Birchmeier; Walter Birchmeier
Genomics | 1994
Cornelia Kraus; Thomas Liehr; Jörg Hülsken; Jürgen Behrens; Walter Birchmeier; Karl-Heinz Grzeschik; Wolfgang G. Ballhausen
Cancer surveys | 1995
Walter Birchmeier; Jörg Hülsken; Jürgen Behrens
Ciba Foundation Symposium 189 - Cell Adhesion and Human Disease | 2007
Walter Birchmeier; Jörg Hülsken; Jürgen Behrens